M&A Deal Summary

Alexza Pharmaceuticals Acquires Symphony Allegro

On August 26, 2009, Alexza Pharmaceuticals acquired life science company Symphony Allegro

Acquisition Highlights
  • This is Alexza Pharmaceuticals’ 1st transaction in the Life Science sector.
  • This is Alexza Pharmaceuticals’ 1st transaction in the United States.
  • This is Alexza Pharmaceuticals’ 1st transaction in Maryland.

M&A Deal Summary
Date 2009-08-26
Target Symphony Allegro
Sector Life Science
Buyer(s) Alexza Pharmaceuticals
Deal Type Add-on Acquisition

Target

Symphony Allegro

Rockville, Maryland, United States
Symphony Allegro, Inc. is a biopharmaceutical company.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Alexza Pharmaceuticals

Mountain View, California, United States
Category Company
Founded 2000
Sector Life Science
Employees28
Revenue 5M USD (2015)
DESCRIPTION

Alexza Pharmaceuticals, Inc. is a developer of drugs for acute and intermittent medical conditions. Their Staccato system aerosolizes without thermal degradation, enabling convenient delivery and rapid therapeutic onset of many small molecule drugs.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Maryland) 1 of 1
Country (United States) 1 of 1
Year (2009) 1 of 1
Mergr

Product

Company

Legal